Luye Medical Group announced that it has recently completed a majority equity investment in Novena Heart Centr...
Luye Pharma’s new drug LY03003 has been submitted to the PMDA in Japan for clinical trials approval
Luye Pharma has entered the final stage of New Drug Application (NDA) submissions for the innovative drug LY03...
TOP